TWO SIGMA INVESTMENTS, LPTWO SIGMA INVESTMENTS, LP

Institutional investor · Portfolio as of Q4 2025

SEC EDGAR SourceSEC Filings

Top Holdings4,041 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction
XLYXLY
ETF

CONSUMER DISCRETIONARY SELT

3.4M$404M0.6%$120.34+0.02%
2 qtrssince 2025-Q3
Increased
71
XLKXLK
ETF

TECHNOLOGY SELECT SECTOR FUND SPDR

2.8M$403.3M0.6%$144.96+0.31%
15 qtrssince 2022-Q2
Increased
71
VUGVUG
ETF

VANGUARD GROWTH ETF

816,840$398.5M0.6%$59.72+35.86%
11 qtrssince 2023-Q2
Decreased
0
IWFIWF
ETF

ISHARES TR RUSSELL 1000 GROWTH INDEX FUND

813,789$385.2M0.5%$94.32+25.23%
11 qtrssince 2023-Q2
Increased
58
102.5M$342.4M0.5%
Increased
44
QQQQQQ
Unit

INVESCO QQQ TRUST SERIES 1 CL USD INC

523,077$321.3M0.5%$443.66+39.62%
28 qtrssince 2019-Q1
Decreased
0
SPYSPY
Unit

STATE STREET SPDR S&P 500 ETF TRUST CL USD INC

464,197$316.5M0.4%$509.77+34.77%
29 qtrssince 2018-Q4
Decreased
0
VNQVNQ
ETF

VANGUARD REAL ESTATE ETF ETF

3.6M$316.2M0.4%$89.220.00%
1 qtr
New
51

MICRON TECHNOLOGY INC

1M$296.8M0.4%$151.01+93.79%
12 qtrssince 2023-Q1
Decreased
0

ADVANCED MICRO DEVICES

1.3M$287.5M0.4%$160.02+33.83%
4 qtrssince 2025-Q1
Decreased
0
62.6M$286.9M0.4%
Decreased
0

PALANTIR TECHNOLOGIES INC-A

1.6M$278.1M0.4%$85.22+112.20%
15 qtrssince 2022-Q2
Decreased
0
IVVIVV
ETF

ISHARES CORE S&P 500 ETF

392,760$269M0.4%$518.59+33.04%
11 qtrssince 2023-Q2
Decreased
0

GENERAL MOTORS CO

3.3M$268.5M0.4%$57.64+42.84%
13 qtrssince 2022-Q4
Decreased
0

AMAZON.COM INC

1.1M$265M0.4%$221.61+4.93%
18 qtrssince 2021-Q3
Decreased
0
TSMTSM
ADR

TAIWAN SEMICONDUCTOR SPONSORED ADR /1 ADR REPS 5 ORD SHS/

868,449$263.9M0.4%$267.80+11.87%
6 qtrssince 2024-Q3
Increased
37

INTUITIVE SURGICAL INC

459,879$260.5M0.4%$481.47+18.93%
22 qtrssince 2020-Q3
Decreased
0

MICROSOFT CORP

538,234$260.3M0.4%$357.77+36.26%
11 qtrssince 2023-Q2
Increased
38

RIVIAN AUTOMOTIVE INC-A

13.2M$260.2M0.4%$13.65+43.48%
4 qtrssince 2025-Q1
Decreased
0

AIRBNB INC-CLASS A

1.9M$259.7M0.4%$129.55+4.76%
5 qtrssince 2024-Q4
Increased
37
$70.9B
AUM
4,041
Positions
Q4 2025
Filing
Rating · 2.5
Quarterly Portfolio Change
+5%Q3'24$44.2B-2%Q4'24$43.5B+6%Q1'25$46B+21%Q2'25$55.5B+17%Q3'25$65.1B+3%Q4'25$67.1B
Activity profile
$ moved · Q4'25
New12%Increased41%Decreased39%Exited7%
Composition
Equity vs derivatives
Equity95%Puts3%Calls2%
Holding period
Avg 4.5 years
<1Q8%1-4Q11%1-2Y6%2Y+75%

TWO SIGMA INVESTMENTS, LP manages $70.9B across 4041 positions as of Q4 2025. Top holdings: XLY (0.6%), XLK (0.6%), VUG (0.6%). Fund DNA: Balanced Allocator. HoldingsIntel Rating: 2.5/5.0.

Q4 2025 Summary

Active quarter - 585 new positions, 469 exits, 1469 increased. Top move: XLY (INCREASED, conviction 71). Portfolio: $70.9B across 4041 positions.

Top holdings by portfolio weight

Total AUM$67B
XLY0.57%
XLK0.57%
VUG0.56%
IWF0.54%
ECHOSTAR COR0.48%
QQQ0.45%
SPY0.45%
VNQ0.45%
MU0.42%
AMD0.41%
Other0.40%

Portfolio allocation by GICS sector

Sectors11
Technology17.26%
Financial Services14.35%
Unknown12.67%
Industrials12.54%
Healthcare11.50%
Consumer Cyclical10.23%
Consumer Defensive4.91%
Basic Materials4.20%
Communication Services4.09%
Real Estate3.37%
Other4.88%

Behavioral investing profile

Checking access…
Balanced Allocator- primarily Technology, Financial Services, Unknown
Compare DNA across all funds
7-dimension quality assessment
Solid(2.5 / 5.0)
Track Record52
Conviction38
Concentration12
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
8Q
AMTBAMTBAMERANT BANCORP INC
Q3 2024 Q2 2026+666,888 shares+$17.1M
8Q
ARCTARCTARCTURUS THERAPEUTICS HLDGS
Q3 2024 Q2 2026+1.1M shares+$7M
8Q
BCRXBCRXBIOCRYST PHARMACEUTICALS INC
Q3 2024 Q2 2026+5.1M shares+$57.4M
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used